TY - JOUR
T1 - Prevalence of Antibiotic Tolerance and Risk for Reinfection among Escherichia coli Bloodstream Isolates
T2 - A Prospective Cohort Study
AU - Lazarovits, Gilad
AU - Gefen, Orit
AU - Cahanian, Noga
AU - Adler, Karen
AU - Fluss, Ronen
AU - Levin-Reisman, Irit
AU - Ronin, Irine
AU - Motro, Yair
AU - Moran-Gilad, Jacob
AU - Balaban, Nathalie Q.
AU - Strahilevitz, Jacob
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
PY - 2022/11/15
Y1 - 2022/11/15
N2 - Background: Tolerance is the ability of bacteria to survive transient exposure to high concentrations of a bactericidal antibiotic without a change in the minimal inhibitory concentration, thereby limiting the efficacy of antimicrobials. The study sought to determine the prevalence of tolerance in a prospective cohort of E. coli bloodstream infection and to explore the association of tolerance with reinfection risk. Methods: Tolerance, determined by the Tolerance Disk Test (TDtest), was tested in a prospective cohort of consecutive patient-unique E. coli bloodstream isolates and a collection of strains from patients who had recurrent blood cultures with E. coli (cohorts 1 and 2, respectively). Selected isolates were further analyzed using time-dependent killing and typed using whole-genome sequencing. Covariate data were retrieved from electronic medical records. The association between tolerance and reinfection was assessed by the Cox proportional-hazards regression and a Poisson regression models. Results: In cohort 1, 8/94 isolates (8.5%) were tolerant. Using multivariate analysis, it was determined that the risk for reinfection in the patients with tolerant index bacteremia was significantly higher than for patients with a nontolerant strain, hazard ratio, 3.98 (95% confidence interval, 1.32-12.01). The prevalence of tolerance among cohort 2 was higher than in cohort 1, 6/21(28.6%) vs 8/94 (8.5%), respectively (P =. 02). Conclusions: Tolerant E. coli are frequently encountered among bloodstream isolates and are associated with an increased risk of reinfection. The TDtest appears to be a practicable approach for tolerance detection and could improve future patient management.
AB - Background: Tolerance is the ability of bacteria to survive transient exposure to high concentrations of a bactericidal antibiotic without a change in the minimal inhibitory concentration, thereby limiting the efficacy of antimicrobials. The study sought to determine the prevalence of tolerance in a prospective cohort of E. coli bloodstream infection and to explore the association of tolerance with reinfection risk. Methods: Tolerance, determined by the Tolerance Disk Test (TDtest), was tested in a prospective cohort of consecutive patient-unique E. coli bloodstream isolates and a collection of strains from patients who had recurrent blood cultures with E. coli (cohorts 1 and 2, respectively). Selected isolates were further analyzed using time-dependent killing and typed using whole-genome sequencing. Covariate data were retrieved from electronic medical records. The association between tolerance and reinfection was assessed by the Cox proportional-hazards regression and a Poisson regression models. Results: In cohort 1, 8/94 isolates (8.5%) were tolerant. Using multivariate analysis, it was determined that the risk for reinfection in the patients with tolerant index bacteremia was significantly higher than for patients with a nontolerant strain, hazard ratio, 3.98 (95% confidence interval, 1.32-12.01). The prevalence of tolerance among cohort 2 was higher than in cohort 1, 6/21(28.6%) vs 8/94 (8.5%), respectively (P =. 02). Conclusions: Tolerant E. coli are frequently encountered among bloodstream isolates and are associated with an increased risk of reinfection. The TDtest appears to be a practicable approach for tolerance detection and could improve future patient management.
KW - antimicrobials
KW - bloodstream infection
KW - tolerance
UR - http://www.scopus.com/inward/record.url?scp=85141756287&partnerID=8YFLogxK
U2 - 10.1093/cid/ciac281
DO - 10.1093/cid/ciac281
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 35451002
AN - SCOPUS:85141756287
SN - 1058-4838
VL - 75
SP - 1706
EP - 1713
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 10
ER -